Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
BioAesthetics logo — company profile

BioAesthetics

Founded 2015 United States United States 10 employees Convertible Note Total: $6.65M Biopharma, Biotechnology +2

General Information

Company Name BioAesthetics
Founded Year 2015
Location United States United States
Employees 10
Industries Biopharma, Biotechnology, Health Care +1
Funding Stage Convertible Note
Social

BounceWatch is an independent company data service, not affiliated with BioAesthetics. To contact BioAesthetics, visit bio-aesthetics.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does BioAesthetics compare?

A PDF of BioAesthetics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting BioAesthetics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About BioAesthetics

BioAesthetics is a biotech startup founded in 2015 as a spin-out from Tulane University. The company focuses on providing improved reconstruction options for breast cancer patients post-mastectomies. Their flagship product, a tissue-engineered nipple-areolar complex (NAC), is designed to be an off-the-shelf, acellular graft for plastic and reconstructive surgeons. This patent-pending product is currently in the pre-clinical phase and aims to serve as a building frame for the patient's body to regenerate their own NAC. With its innovative approach, BioAesthetics has caught the attention of investors, receiving a Convertible Note investment from SOSV and indiebio on 26 September 2023. Operating in Biopharma, Biotechnology, Health Care, and Life Sciences, BioAesthetics is poised to make a significant impact in the field of breast reconstruction.

Business keywords: Breast Cancer, Tissue Engineering, Healthcare Innovation, Startup, Medical Research, University Spin-out, Reconstructive Surgery, Pre-clinical Phase

Funding Rounds & Investors (7)

View All
Funding Stage Amount Investors Lead Investors Date
Convertible Note Undisclosed 2
SOSV indiebio
SOSV, indiebio
26 Sep 2023
Grant $251.21K 1
National Science Foundation
National Science Foundation
10 Dec 2020
Series A $6.40M 10
Joyance Partners SOSV indiebio
Joyance Partners, SOSV +8
05 Oct 2020
Grant $3.00K 1
North Carolina Biotechnology Center
04 Aug 2020
Convertible Note Undisclosed 2
SOSV indiebio
SOSV, indiebio
24 Jul 2019
Seed Round Undisclosed 6
SOSV indiebio Hemi Ventures
SOSV, indiebio +4
08 Sep 2017
Seed Round Undisclosed 3
SOSV indiebio New Orleans Biofund
SOSV, indiebio +1
09 May 2017

BioAesthetics Alternatives & Competitors

View All Alternatives
BioAesthetics vs
Micrima Limited
Micrima Limited United Kingdom

Redefining Cancer Diagnostics

Series D
26 employees
Biotechnology, Health Care
Compare BioAesthetics vs Micrima Limited
BioAesthetics vs
KYLYS
KYLYS Switzerland

BIOMOLECULES NOW, FOR YOUR FUTURE

Debt Financing
3 employees
Biotechnology, Life Sciences
BioAesthetics vs
OncoRes Medical
OncoRes Medical Australia

Transforming the standard of care in breast cancer surgery.

42 employees
Biotechnology, Health Care
View all alternatives

FAQ About BioAesthetics

BioAesthetics was founded in 2015 as a Tulane University spin-out with the mission to improve reconstruction options for breast cancer patients after they undergo mastectomies. The BioAesthetics’ initial product is a tissue-engineered nipple-areolar complex (NAC). This product will be provided to pl...
BioAesthetics was founded in 2015.
BioAesthetics is headquartered in United States.
BioAesthetics operates in Biopharma, Biotechnology, Health Care and Life Sciences. Its work centres on Breast Cancer, Tissue Engineering, Healthcare Innovation and Startup.
BioAesthetics has approximately 10 employees.
BioAesthetics has completed 7 funding rounds, raising a total of $6.65M. The latest funding stage is Convertible Note.
Top alternatives and competitors to BioAesthetics include Micrima Limited, KYLYS, OncoRes Medical, Atossa Therapeutics, VoxCell. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
BioAesthetics and Micrima Limited are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for BioAesthetics, https://bouncewatch.com/company/bioaesthetics, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes